The aim of this study is to describe and compare the onset of neuromuscular block and recovery after reversal of NMBAs at two different muscle/nerve units: foot (posterior tibial n. and flexor hallucis brevis m.) and forearm (ulnar n. and adductor pollicis m.), as measured by a new quantitative monitor, the electromyography-based TetraGraph
Latest Information Update: 03 Dec 2021
At a glance
- Drugs Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 03 Dec 2021 New trial record
- 12 Oct 2021 Results presented at the ANESTHESIOLOGY 2021 Annual Meeting of the American Society of Anesthesiologists